Latest filing published 11 Feb 2019 for GlaxoSmithKline plc.
Insider track record
No signal scores available.
Roger Connor: trading record in brief
Roger Connor discloses dealings in GlaxoSmithKline plc to RNS (LSE). We count 3 filings; the first trade dates from 26 April 2018 and the latest from 8 February 2019.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
On 11 February 2019 came the latest disclosure, a transaction in GlaxoSmithKline plc. The median gap between a trade and its publication by RNS (LSE) is 1 day. For comparison, UK MAR gives managers three business days to notify a trade. This summary is built from RNS (LSE) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Roger Connor
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 6,000 sharesn/aISIN GB0009252882FCA-NSM:LSE20190211123855_13965116_20200326185110102_19467-1
- 49,152 sharesn/aISIN GB0009252882FCA-NSM:LSE20180427124349_13622055_20200330111351032_1735-0
- 49,152 sharesn/aISIN GB0009252882FCA-NSM:LSE20180427124349_13622055_20200330111351032_1735-1
3 of 3 declarations